Argenica Therapeutics Limited (ASX:AGN)

Argenica Therapeutics Revenue

Argenica Therapeutics had revenue of 2.83M AUD in the half year ending December 31, 2024, with 105.66% growth. This brings the company's revenue in the last twelve months to 3.08M, up 13.03% year-over-year. In the fiscal year ending June 30, 2024, Argenica Therapeutics had annual revenue of 2.60M with 48.46% growth.

• Revenue (ttm): 3.08M
• Revenue Growth: +13.03%
• P/S Ratio: 29.61
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 91.20M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	2.60M	848.04K	48.46%
Jun 30, 2023	1.75M	1.49M	575.38%
Jun 30, 2022	259.10K	-36.98K	-12.49%
Jun 30, 2021	296.08K	-	-
Jun 30, 2020	-	-	-